Ascelus-H: A trial investigating the use of digital follow up for monitoring long term blood conditions

An observational trial of patients with long-term blood conditions using the Ascelus app for digital follow up.

You can share the following isrctn.com Identifier with your medical team so they can find out more about the trial: ISRCTN15125462

Trial aim and background  

The aim of this trial is to investigate whether there is a better way to monitor patients with long-term stable blood conditions. At the moment patients have to attend hospital clinics at regular intervals to keep an eye on their condition. In this study the participants will download an app which they can use to track their condition, view blood results and report any new symptoms.

Patients may be recruited to join focus groups, interviews, and user experience testing to help design the Ascelus app. Further patients will download the app to monitor their condition over 12 months.

Who can enter 

This study is open to adults with chronic lymphocytic leukaemia (CLL) and Waldenstrom’s macroglobulinaemia (WM). The condition must be stable and the patient be under the care of one of the participating trusts.

Locations 

Recruitment is taking place in the following UK locations:

  • Kings College Hospital NHS Foundation Trust, London
  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

Further information 

More information about what treatments are involved, the criteria you must meet in order to take part in the trial and where this trial is taking place are available at: https://www.isrctn.com/ISRCTN15125462

Lymphoma Action are not able to refer people to specific trials. If you are interested in taking part in this trial we recommend that you print the trial summary and discuss it with your medical team. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.